Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment - PubMed (original) (raw)
Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment
Rosalinda C Roberts et al. Synapse. 2002 Aug.
Abstract
Antipsychotic drugs (APD) are used in the treatment of schizophrenia and other psychotic disorders and exert their effects, in part, through dopamine receptor blockade. APD treatment causes many changes in the brains of humans and experimental animals including therapeutic, pathologic, or changes associated with motor side effects. Typical APD given chronically to animals induce behavioral sequelae that mimic tardive dyskinesia in several ways. Our previous work has shown that chronic treatment with haloperidol decreases striatal synaptic density but that symmetric synapses are lost only in rats that develop oral dyskinesias. The goals of this study were to determine if the density of dopaminergic terminals was affected by chronic haloperidol treatment and/or correlated with dyskinesias. Rats were given haloperidol (1.5 mg/kg/rat) or water, as a control. After 6 months of treatment, rats were divided into nondyskinetic or dyskinetic groups according to the behavior scores determined in the last month. Striatal volume was similar between controls and drug-treated rats. Synaptic density, calculated using stereological methods, was obtained from the matrix of the ventrolateral striatum. The density of symmetric synapses (mean +/- SD, per 100/microm(3)) formed by tyrosine hydroxylase (TH) containing terminals in haloperidol treated rats (3.58 +/- 1.64) was not significantly different from that of controls (3.06 +/- 1.00). The density of TH-labeled terminals forming symmetric synapses in the nondyskinetic group (3.65 +/- 1.67) vs. the dyskinetic group (3.54 +/- 1.73) was similar and neither was different from that of the controls. These data indicate that terminals other than dopaminergic ones form fewer symmetric synapses in dyskinetic rats. Moreover, these data have implications for interpreting results obtained in humans treated with typical antipsychotic drugs.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
- Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC, Gaither LA, Gao XM, Kashyap SM, Tamminga CA. Roberts RC, et al. Synapse. 1995 Jul;20(3):234-43. doi: 10.1002/syn.890200307. Synapse. 1995. PMID: 7570355 - Effect of chronic olanzapine treatment on striatal synaptic organization.
Roberts RC. Roberts RC. Synapse. 2001 Jan;39(1):8-15. doi: 10.1002/1098-2396(20010101)39:1<8::AID-SYN2>3.0.CO;2-K. Synapse. 2001. PMID: 11071704 - Single dopaminergic nigrostriatal neurons form two chemically distinct synaptic types: possible transmitter segregation within neurons.
Hattori T, Takada M, Moriizumi T, Van der Kooy D. Hattori T, et al. J Comp Neurol. 1991 Jul 15;309(3):391-401. doi: 10.1002/cne.903090308. J Comp Neurol. 1991. PMID: 1717519 - Long-term haloperidol treatment and factors affecting the activity of striatal tyrosine hydroxylase.
Lovenberg W, Alphs L, Pradhan S, Bruckwick E, Levine R. Lovenberg W, et al. Adv Biochem Psychopharmacol. 1980;24:9-15. Adv Biochem Psychopharmacol. 1980. PMID: 6105810 Review. No abstract available. - Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons.
Hong JS, Yang HY, Gillin JC, Costa E. Hong JS, et al. Adv Biochem Psychopharmacol. 1980;24:223-32. Adv Biochem Psychopharmacol. 1980. PMID: 6105776 Review. No abstract available.
Cited by
- Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays.
Perez-Costas E, Guidetti P, Melendez-Ferro M, Kelley JJ, Roberts RC. Perez-Costas E, et al. J Neural Transm (Vienna). 2008 May;115(5):745-53. doi: 10.1007/s00702-007-0004-5. Epub 2008 Jan 11. J Neural Transm (Vienna). 2008. PMID: 18193153 Free PMC article. - Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons.
Berlanga ML, Price DL, Phung BS, Giuly R, Terada M, Yamada N, Cyr M, Caron MG, Laakso A, Martone ME, Ellisman MH. Berlanga ML, et al. Brain Res. 2011 May 16;1390:41-9. doi: 10.1016/j.brainres.2011.03.044. Epub 2011 Mar 24. Brain Res. 2011. PMID: 21439946 Free PMC article. - Dopaminergic modulation of axon collaterals interconnecting spiny neurons of the rat striatum.
Guzmán JN, Hernández A, Galarraga E, Tapia D, Laville A, Vergara R, Aceves J, Bargas J. Guzmán JN, et al. J Neurosci. 2003 Oct 1;23(26):8931-40. doi: 10.1523/JNEUROSCI.23-26-08931.2003. J Neurosci. 2003. PMID: 14523095 Free PMC article. - Novel gene signatures predicting and immune infiltration analysis in Parkinson's disease: based on combining random forest with artificial neural network.
Xie S, Peng P, Dong X, Yuan J, Liang J. Xie S, et al. Neurol Sci. 2024 Jun;45(6):2681-2696. doi: 10.1007/s10072-023-07299-2. Epub 2024 Jan 24. Neurol Sci. 2024. PMID: 38265536
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources